Acute Effects of Sublingual Nifedipine in Patients with Raynaudʼs Phenomenon
- 1 May 1987
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 9 (5) , 628-631
- https://doi.org/10.1097/00005344-198705000-00018
Abstract
Measurements of peripheral blood flow using bolometry, thermography, ultrasonic Doppler index, and laser light scattering were made in nine patients with primary Raynaud''s phenomenon before and after administration of 20 mg sublingual nifedipine and matching placebo. Following nifedipine treatment, there was some evidence of protection against reduction in blood flow, suggesting that this way of taking nifedipine is helpful. Self-administration of sublingual nifedipine before cold exposure may be an effective way of preventing the development of attacks of Raynaud''s phenomenon is contrast with the conventional form of regular oral administration.This publication has 3 references indexed in Scilit:
- Aspects of laser light scattering from skin tissue with application to laser Doppler blood flow measurementPhysics in Medicine & Biology, 1984
- Nifedipine as a therapeutic modality for raynaud's phenomenonArthritis & Rheumatism, 1983
- CONTROLLED TRIAL OF NIFEDIPINE IN THE TREATMENT OF RAYNAUD'S PHENOMENONThe Lancet, 1982